
16.27 Delayed Data As of May 19 | ![]() Today’s Change | 14.78 Today|||52-Week Range 33.09 | -48.84% Year-to-Date |
Merus N.V. (MRUS) Reports Q1 Loss, Tops Revenue Estimates May 09 / Zacks.com - Paid Partner Content |
Previous close | 15.81 |
Today’s open | 16.05 |
Day’s range | 15.51 - 16.35 |
Volume | 156,207 |
Average volume (3 months) | 193,701 |
Market cap | $695.5M |
Earnings growth (last year) | +40.84% |
Earnings growth (this year) | -53.49% |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | +64.00% |
P/E ratio | NM |
Price/Sales | 25.02 |
Price/Book | 2.20 |
Today’s change | Today’s % change | |
---|---|---|
NSTGNanoString Technolog... | +0.99 | +6.62% |
REPLReplimune Group Inc | +0.15 | +1.05% |
NKTRNektar Therapeutics | +0.11 | +2.89% |
CDMOAvid Bioservices Inc | +0.86 | +7.39% |
Next reporting date | August 12, 2022 |
EPS forecast (this quarter) | -$0.58 |
Annual revenue (last year) | $49.1M |
Annual profit (last year) | -$66.8M |
Net profit margin | -136.06% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Utrecht, Utrecht |